非编码RNA-GATA轴:癌症进展和转移的机制和影响
Aviral Kumar1, Uzini Devi Daimary1, Mangala Hegde1
1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781039, Assam, India.
Cancers
|January 10, 2026
概括
GATA转录因子调节组织发育和细胞周期. 它们的失调驱动癌症的进展,这篇评论探讨了非编码RNA如何与癌症中的GATA因素相互作用.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- GATA转录因子是组织发育,细胞分化和平衡的关键调节者.
- 失调的GATA因子涉及瘤发生,癌症进展和转移,影响瘤过程.
- 非编码RNAs关键调节基因表达,并且正在成为癌症的关键参与者.
研究的目的:
- 审查GATA因子在上皮层-介质细胞过渡 (EMT) 和转移中的作用.
- 探索癌症中非编码RNA和GATA转录因子之间的大部分未被研究的相互作用.
- 为潜在的治疗向和生物标志物发现提出一个新的监管轴.
主要方法:
- 文献综述侧重于GATA因素,非编码RNA和癌症进展.
- 对GATA因子在发育和疾病中的作用进行现有研究的分析.
- 对非编码RNA介导的基因表达调节的研究结果的综合.
主要成果:
- GATA因子促进原生细胞的增殖和分化细胞的细胞循环停止.
- GATA因子的突变与预后不佳相关,并影响多种瘤性途径.
- 非编码RNA可以通过调节基因表达来作为瘤抑制剂或瘤基因.
结论:
- GATA因素在癌症中扮演着复杂的,取决于背景的角色,影响EMT和转移.
- 癌症进展中的非编码RNA和GATA因子之间的相互作用是一个关键的,未被充分研究的领域.
- 了解这种相互作用可能会揭示癌症治疗的新生物标志物和治疗策略.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
02:39lncRNA - Long Non-coding RNAs
3.5K
3.5K
01:41Non-Canonical Wnt Signaling Pathways
8.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
01:24Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
02:30Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K